Genpact Limited (NYSE:G) Receives $48.44 Consensus Price Target from Analysts

Genpact Limited (NYSE:GGet Free Report) has received a consensus recommendation of “Hold” from the nine research firms that are presently covering the company, MarketBeat reports. Six analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $48.44.

G has been the topic of a number of analyst reports. Jefferies Financial Group raised shares of Genpact from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. TD Cowen raised shares of Genpact from a “hold” rating to a “buy” rating and boosted their target price for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Needham & Company LLC boosted their target price on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Mizuho boosted their target price on shares of Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Finally, Robert W. Baird boosted their target price on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th.

Check Out Our Latest Analysis on Genpact

Insiders Place Their Bets

In other news, SVP Piyush Mehta sold 12,000 shares of the company’s stock in a transaction on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the sale, the senior vice president now owns 151,182 shares of the company’s stock, valued at $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the company’s stock in a transaction on Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the sale, the chief executive officer now directly owns 267,404 shares of the company’s stock, valued at $11,926,218.40. The trade was a 4.84 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Genpact

A number of large investors have recently modified their holdings of G. Coppell Advisory Solutions LLC grew its holdings in shares of Genpact by 529.5% in the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider’s stock valued at $25,000 after purchasing an additional 503 shares during the period. SRH Advisors LLC purchased a new stake in shares of Genpact in the fourth quarter valued at about $26,000. Atlas Capital Advisors Inc. grew its holdings in shares of Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider’s stock valued at $26,000 after purchasing an additional 216 shares during the period. Manchester Capital Management LLC purchased a new stake in shares of Genpact in the fourth quarter valued at about $38,000. Finally, GeoWealth Management LLC grew its holdings in shares of Genpact by 199.0% in the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider’s stock valued at $38,000 after purchasing an additional 583 shares during the period. Hedge funds and other institutional investors own 96.03% of the company’s stock.

Genpact Trading Up 1.0 %

Shares of G opened at $53.22 on Wednesday. Genpact has a 1-year low of $30.23 and a 1-year high of $56.76. The company has a 50-day moving average of $47.78 and a 200 day moving average of $43.26. The firm has a market capitalization of $9.39 billion, a price-to-earnings ratio of 18.74, a PEG ratio of 1.84 and a beta of 1.20. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85.

Genpact (NYSE:GGet Free Report) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, research analysts expect that Genpact will post 3.21 EPS for the current year.

Genpact Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, March 11th. This is a boost from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.28%. Genpact’s dividend payout ratio is currently 23.94%.

Genpact Company Profile

(Get Free Report

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Analyst Recommendations for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.